BGMS BGMS
Company Profile ↓Company Overview
BGMS (BGMS) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue -100.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -100.00% |
Stock Price Performance
| 1 Year: | -89.40% |
| 6 Months: | +0.00% |
| 3 Months: | +0.97% |
| 1 Month: | +18.18% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)62.25 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 89.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2013 | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 743.00K |
| Operating Income | -4.05M | -4.15M | -5.79M | -5.41M | -5.58M | -5.67M | -5.30M | -3.62M | -3.39M | -3.74M | -3.76M | -3.48M | -2.69M | -2.49M | -2.11M | -2.16M | -2.46M | -2.46M | -2.20M | -2.34M | -2.35M | -2.42M | -2.47M | -2.57M | -4.30M | -6.10M | -6.00M | -6.56M | -5.79M | -6.47M | -7.32M | -5.93M | -6.84M | -4.36M | -3.64M | -2.18M | -4.21M | -1.32M | -992.00K | -246.00K |
| Net Income | -3.08M | 1.49M | -5.00M | -4.87M | -4.81M | -4.91M | -4.91M | -3.35M | -2.71M | -3.04M | -2.96M | -2.95M | -1.55M | -2.19M | -1.86M | -1.35M | -1.85M | -2.07M | -1.84M | -1.78M | -1.90M | -1.22M | -2.17M | -2.26M | -3.48M | -5.13M | -4.99M | -4.11M | -4.58M | -5.10M | -5.80M | -5.45M | -6.03M | -2.95M | -3.26M | -1.96M | -81.00K | -1.32M | -988.00K | -197.00K |
| Diluted EPS | - | 0.10 | - | - | -0.22 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.50 | -0.56 | -0.54 | -0.42 | -0.46 | -0.42 | -7.00 | -0.44 | - | -2.27 | -172.18 | -43.80 | 0.00 | -0.98 | -1.31 | - |
| R&D Expense | 1.58M | 2.63M | 4.58M | 4.34M | 4.54M | 4.97M | 4.34M | 2.58M | 2.90M | 2.50M | 2.64M | 2.41M | 1.31M | 1.22M | 958.00K | 798.00K | 1.18M | 1.21M | 1.01M | 1.15M | 1.06M | 1.11M | 1.16M | 1.07M | 2.57M | 4.10M | 4.22M | 4.95M | 4.21M | 4.41M | 5.67M | 4.73M | 5.24M | 2.80M | 2.02M | 950.00K | 822.00K | 68.00K | 5.00K | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 1998 | Mar 1999 | Mar 2000 | Mar 2001 | Mar 2002 | Mar 2003 | Dec 2004 | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | 911.00K | 112.00K | 699.00K | 69.00K | 1.08M | 1.73M | 1.94M | 843.00K | 0 | 150.00K | - | 0 | 0 | 0 | 420.00K | 43.00K | 0 |
| Operating Income | - | - | - | - | - | - | - | - | - | - | - | -18.30M | -15.13M | -15.75M | -15.10M | -17.97M | -22.44M | -16.17M | -14.15M | -9.49M | -9.55M | -9.68M | -10.64M | -22.94M | -27.66M | -25.45M | -12.00M | -8.43M |
| Net Income | -2.53M | -3.96M | -5.69M | -10.38M | -14.85M | -15.54M | -22.74M | -18.05M | -29.26M | -24.05M | -40.39M | -19.57M | -16.02M | -15.24M | -13.19M | -10.15M | -19.39M | -14.34M | -11.79M | -7.47M | -7.29M | -7.83M | -8.45M | -18.89M | -21.20M | -22.55M | -11.21M | -3.00M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.42 | -2.14 | -27.24 | -26.75 | -502.46 | -6.45 |
| R&D Expense | - | - | - | - | - | - | - | - | - | - | - | 9.77M | 6.41M | 9.21M | 6.59M | 11.28M | 18.28M | 12.38M | 9.48M | 4.24M | 4.33M | 4.66M | 4.76M | 15.48M | 20.27M | 19.16M | 6.66M | 848.00K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 1997 | Mar 1998 | Mar 1999 | Mar 2000 | Mar 2001 | Mar 2002 | Mar 2003 | Dec 2003 | Dec 2004 | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31.46M | 26.00M | 19.35M | 35.52M | 29.39M | 24.76M | 19.66M | 26.00M | 19.82M | 15.31M | 36.80M | 42.59M | 28.05M | 8.80M | 4.09M | 8.19M |
| Total Equity | -293.00K | 2.01M | -1.54M | 7.98M | -2.59M | -15.08M | -32.15M | 37.65M | 23.95M | 4.12M | 53.92M | 57.97M | 20.64M | 5.87M | 24.92M | 19.50M | 10.02M | 28.02M | 21.69M | 18.84M | 14.27M | 21.77M | 15.27M | 11.70M | 33.26M | 37.69M | 15.94M | 607.00K | -2.17M | 6.84M |
| Cash & Equivalents | - | - | - | - | - | - | - | - | - | - | - | - | 24.22M | 11.49M | 29.50M | 24.45M | 16.41M | 31.15M | 24.19M | 20.44M | 16.52M | 23.91M | 17.50M | 11.88M | 33.41M | 36.56M | 18.34M | 3.38M | 3.14M | 3.50M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.54M | 6.50M | 9.34M | 7.50M | 7.70M | 5.93M | 5.39M | 4.24M | 4.55M | 3.61M | 3.54M | 5.32M | 7.62M | 8.20M | 6.27M | 1.34M |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.54M | 6.50M | 9.34M | 7.26M | 7.49M | 5.75M | 5.26M | 4.11M | 4.45M | 2.42M | 2.49M | 5.29M | 7.51M | 8.16M | 6.27M | 1.33M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - | - | - | -7.48M | -6.70M | -9.45M | -7.93M | -18.54M | -20.83M | -16.11M | -7.99M | -4.77M |
| Investing Cash Flow | - | - | - | - | - | - | - | - | -13.00K | -39.00K | 28.00K | -96.00K | -27.00K | -7.00K | -6.00K | - | - |
| Financing Cash Flow | - | - | - | - | - | - | - | - | 14.75M | 429.00K | 3.85M | 29.50M | 21.74M | 3.00M | 848.00K | 7.82M | 5.26M |
| Capital Expenditure | -15.00K | -8.00K | -6.00K | -12.00K | -208.00K | -309.00K | -34.00K | -3.00K | -13.00K | -39.00K | -10.00K | -96.00K | -27.00K | -7.00K | -6.00K | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | -7.49M | -6.74M | -9.46M | -8.03M | -18.57M | -20.83M | -16.12M | - | - |
Ratios (Annual)
Figures in %.
| Metric | Mar 1998 | Mar 1999 | Mar 2000 | Mar 2001 | Mar 2002 | Mar 2003 | Dec 2004 | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | -2,009.2% | -13,513.4% | -2,252.9% | -21,888.4% | -1,658.1% | -1,293.9% | -831.8% | -1,678.5% | - | -6,365.3% | - | - | - | - | -6,060.2% | -27,916.3% | - |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | -2,148.2% | -14,304.5% | -2,180.7% | -19,110.1% | -936.6% | -1,118.1% | -737.8% | -1,398.7% | - | -4,858.7% | - | - | - | - | -5,370.2% | -26,074.4% | - |
| ROE % | -126.1% | 257.7% | -71.2% | 400.8% | 98.5% | 48.3% | -94.9% | -438.2% | -54.3% | -41.5% | -195.6% | -333.3% | -64.3% | -78.2% | -131.6% | -36.2% | -89.4% | -76.1% | -82.6% | -34.3% | -47.7% | -66.9% | -25.4% | -50.1% | -133.0% | -3,715.8% | 515.7% | -43.8% |
| ROCE % | - | - | - | - | - | - | - | - | - | - | - | - | -60.7% | -80.8% | -150.7% | -63.6% | -102.5% | -85.1% | -98.2% | -43.4% | -62.1% | -75.1% | -31.0% | -61.5% | -134.7% | -3,952.3% | 552.2% | -123.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BGMS
Bio Green Med Solution (BGMS) surges after announcing all-stock business combination with Future NRG - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxQT1N0SFpzRGszUHhpMnlwYVB4aEF4RkExdmhtZ2ppbEFVYkxMcnNQalVwX3lhRzFCQVY4dWxacjlfaVBfamJJcUIwcmFKQ0JhSFl6dWlDQXM2UHlzYl9ndF9wNEw2MFpXQXpnR1JTcFpTSnJzaFhHdGFZdkE1N1YyZjdkQU9PbWE2OTI3MU…
Future NRG to control Bio Green Med in all-stock merger (NASDAQ: BGMS) - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNUmxIZTUxUEtYTE45MWI1MW5sa0tlSWZXRVB2dkFCSUFINU50VDltakY0dEpPNlZuU2M1bHkzdE9NajdfNjhyWWJ1Z19XOFFndF93ZE81MzYyZHhQRlZsUDFSUGRuazdfdGxMb1hZQ2VLTEc0Y1pYQnNmNEFreXg0YTVnUWdqYUFfSkMzNm…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE5fT0JVTEJtY3N4ZVg0bk5QZ1BOallpQXRaejBQYkFUbEJqd2szMHUxQXpXMzdYdUk1RG91el9nb0k2ekdtUThMYTlFSlNkU091?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Bio Green Med Solution, Inc. Revenue Breakdown – NASDAQ:BGMS - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFBZX001R0dWYkF5d2RRWGVmbUlwWDJDYUFwZWRQbXE3cnpvZ0RUNGc1UGo0OXRCbGM2aGx5RjRnNEE4Q0J1T1BiMzFYcC1OZVE0OVNPM3k0VTVMTGlxNkhScVNDMEdjWk8xTFRlZUxYZGJMR3NSR01v?oc=5" target="_blank">Bio Gre…
Bio Green Med Solution Surges 172% After Announcing Deal to Acquire Malaysia Waste Tech Company - Benzinga
<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxPYkcyaXhXXzhpb0otUHJUWm5aX1hkRWxjMDZGOUpIcFVwYVFuR1p3UXU3aUF0NFlJSmpzRlc3NmFjbWlXdkdLbXVQRTBFZFhqaGFXSzNNdXgwcTF2bktnQTdmeXdlOFhRS0N4T080X1Q3OGtfZTh0SG54SnI4NE5IRFN5U3hDdW5ncHl1an…
Stocks to watch on Thursday after-hours: LULU, RBRK, BGMS, DOCU (LULU:NASDAQ) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNSmVWNmVDeGlrM0U1SVVKNTdyVkl2N3dweHBTbFRyS0ZBTmdtc3ZRYm8ta1RFXzg2M253TEZSd1JGZkIwQThpc1VOWk52QXQ5UnlvNHBqVW8yQ2JKQ0o2cEtqZ3ZUNUFzVmM0ZkcyNElKcnpSWnlIYXVManBHeGg0TTRILTloMG1ZYlJlUU…
BGMS — Frequently Asked Questions
What is the current share price of BGMS?
As of 2026-08-05 17:25 PDT, BGMS trades at $1.04 on NASDAQ/NYSE. Its 52-week range is $0.60 to $9.81.
What is the P/E ratio of BGMS?
BGMS trades at a trailing price-to-earnings (P/E) ratio of -0.16.
What is the return on equity (ROE) of BGMS?
BGMS has a return on equity (ROE) of -43.82%. Its return on capital employed (ROCE) is -122.97%.
Is BGMS a good stock to buy?
This page provides a data-driven analysis of BGMS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.